Box 1.

Glass Report – Highlights of Reported Resistance

1. High rates of AMR observed against common bacterial infections

2. Median frequency of resistance in pathogens isolated from patients with bloodstream infections

i. Methicillin-resistant S. aureus (MRSA): 12.11% (IQR 6.4–26.4)

ii. E. coli resistant to third-generation cephalosporins: 36.0% (IQR 15.2–63.0)

iii. K. pneumoniae resistant to third-generation cephalosporins 57.6% (IQR 33.4–77.8), with 12 countries reporting 80–100% resistance

iv. Acinetobacter spp.: aminoglycosides 41.2% (IQR 5.20–83.31); carbapenems 63.2% (IQR 19.78 −81.63)

3. Median resistance to ciprofloxacin in urinary tract infections

i. 43.29% (IQR 23.8–46.4) for E. coli in 33 reporting countries, territories and areas

ii. 38.1% (IQR 8.41–63.53) for K. pneumoniae in 34 reporting countries, territories and areas

Note: Data from World Health Organization.¹¹